Search for: "Generic Pharmaceutical Association" Results 81 - 100 of 3,014
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2023, 5:16 am by Moll Law Group
More than $1.5 billion in sales were generated by Eli Lilly in the first half of 2023, which is a year after it was approved in the United States. [read post]
13 Nov 2023, 6:43 am by Daniel G. Aaron
Pharmaceutical development in the U.S. has largely been privatized, with private companies submitting data on new drugs to be reviewed by the U.S. [read post]
10 Nov 2023, 1:35 pm by Cynthia Marcotte Stamer
Child Tax Credit For taxable years beginning in 2024, the amount used in Code § 24(d)(1)(A) to determine the amount of credit under § 24 that may be refundable is $1,700. .06 Earned Income Credit. (1) In general. [read post]
9 Nov 2023, 7:12 pm by Jason Noakes
  List of 78 Modern Awards affected Aboriginal and Torres Strait Islander Health Workers and Practitioners and Aboriginal Community Controlled Health Services Award 2020 (clause 22.3) Aircraft Cabin Crew Award 2020 (clause 19.4) Airline Operations – Ground Staff Award 2020 (clause 22.6) Alpine Resorts Award 2020 (clause 25.3) Aluminium Industry Award 2020 (clause 22.4) Ambulance and Patient Transport Industry Award 2020 (clause 22.7) Animal Care and Veterinary Services Award 2020 (clause… [read post]
9 Nov 2023, 1:48 pm by Cynthia Marcotte Stamer
  As a part of this work, she has continuously and extensively worked with domestic and international hospitals, health care systems, clinics, skilled nursing, long term care, rehabilitation and other health care providers and facilities; medical staff, accreditation, peer review and quality committees and organizations; billing, utilization management, management services organizations, group purchasing organizations; pharmaceutical, pharmacy, and prescription benefit management and… [read post]
9 Nov 2023, 1:07 pm by Cynthia Marcotte Stamer
Child Tax Credit For taxable years beginning in 2024, the amount used in Code § 24(d)(1)(A) to determine the amount of credit under § 24 that may be refundable is $1,700. .06 Earned Income Credit. (1) In general. [read post]
9 Nov 2023, 5:00 am by The Petrie-Flom Center Staff
Americans spend more on pharmaceuticals compared to peer nations, with generic and brand name drugs costing consumers  2.5 to 4 times more in the U.S. [read post]
6 Nov 2023, 1:00 pm by jeffreynewmanadmin
” “The duty to report suspicious orders and other reporting requirements imposed on wholesale pharmaceutical distributors by the Controlled Substance Act is critical to ensuring the safety of our citizens from potential harm, including those associated with drug diversion, drug tampering and drug overdoses resulting from illegal drug sales and consumption,” said U.S. [read post]
Nine of the life sciences focused initiatives will be coordinated by ABIFINA, two by Interfarma, and one by the FarmaBrasil Group (a Brazilian association of generic companies). 4 – Standard Essential Patents (SEPs) will be addressed The plan contains one action targeting SEPs, which is described in very generic, open-ended terms: “promote dialogue, study and dissemination of good practices regarding the adoption of solutions and conditions for licensing… [read post]
5 Nov 2023, 3:10 pm by Cynthia Marcotte Stamer
Reasonable cause means an act or omission in which a covered. entity or business associate knew, or by exercising reasonable diligence would have known, that the act or omission violated an administrative simplification provision, but in which the covered entity or business associate did not act with willful neglect. [read post]
4 Oct 2023, 10:00 pm by Kurt R. Karst
The Plaintiffs in the remaining five lawsuits (Merck, Bristol Myers Squibb, PhRMA and other trade associations, Janssen pharmaceutical, and Boehringer Ingelheim) might similarly amend their complaints to note that their drugs were in fact selected, and that they were compelled to sign contracts with the CMS. [read post]
3 Oct 2023, 6:30 am by Guest Blogger
As the Constitutional Court recognized in its important Pharmaceutical Manufacturers judgment, “Courts no longer have to claim space and push boundaries to find means of controlling public power. [read post]
28 Sep 2023, 10:09 am by The Petrie-Flom Center Staff
Nikhil Chaudhry is a Postgraduate Associate at the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency. [read post]
26 Sep 2023, 4:49 am by Ani Oganesian (US)
Background: The Orange Book Currently, the federal law known as the Hatch-Waxman Act requires pharmaceutical patent holders to list their branded drugs and the associated patents in the “Orange Book,” formally known as the FDA’s publication of “Approved Drug Products with Therapeutic Equivalence Evaluations. [read post]
26 Sep 2023, 4:49 am by Ani Oganesian (US)
Background: The Orange Book Currently, the federal law known as the Hatch-Waxman Act requires pharmaceutical patent holders to list their branded drugs and the associated patents in the “Orange Book,” formally known as the FDA’s publication of “Approved Drug Products with Therapeutic Equivalence Evaluations. [read post]
22 Sep 2023, 4:00 am by Jim Sedor
Louis Milione retired from the DEA a second time this summer amid reporting on potential conflicts caused by his prior consulting for the pharmaceutical industry. [read post]
19 Sep 2023, 6:30 am by Michelle Kendler-Kretsch
According to corporate records and a report from South Sudan’s auditor general, a company half-owned by a 9-month-old baby received a letter of credit — a bank’s guarantee that it will provide loaned funds for a purchase or other financial transaction — to import pharmaceutical products into South Sudan. [read post]
18 Sep 2023, 9:05 pm by Cookson Beecher
The company’s thinking is that if you want to make a dent in animal husbandry and the environment by the next generation, the product requires mass adoption. [read post]